Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-09 4:23 pm Purchase | 13G | Passage BIO Inc. PASG | LAV Prescience Ltd | 2,827,328 6.2% | 2,827,328 (New Position) | View |
2021-02-08 10:29 am Purchase | 13G | Passage BIO Inc. PASG | FMR LLC | 5,278,100 11.591% | 650,502 (+14.06%) | View |
2021-01-28 1:48 pm Unchanged | 13D | Passage BIO Inc. PASG | ORBIMED ADVISORS LLC | 5,947,323 11.2% | 0 (Unchanged) | View |
2021-01-27 2:56 pm Purchase | 13D | Passage BIO Inc. PASG | Frazier Life Sciences IX L.P. | 5,021,438 9.5% | 12,219 (+0.24%) | View |
2020-06-10 10:13 am Purchase | 13G | Passage BIO Inc. PASG | FMR LLC | 4,627,598 10.204% | 4,627,598 (New Position) | View |
2020-03-13 4:52 pm Purchase | 13D | Passage BIO Inc. PASG | Versant Venture Capital VI L.P. | 4,026,417 9.2% | 4,026,417 (New Position) | View |
2020-03-12 1:23 pm Purchase | 13G | Passage BIO Inc. PASG | Access Industries Holdings LLC | 2,616,630 5.9% | 2,616,630 (New Position) | View |
2020-03-09 5:16 pm Purchase | 13D | Passage BIO Inc. PASG | Frazier Life Sciences IX L.P. | 5,009,219 10.9% | 5,009,219 (New Position) | View |
2020-03-09 4:53 pm Purchase | 13D | Passage BIO Inc. PASG | ORBIMED ADVISORS LLC | 5,947,323 13.5% | 5,947,323 (New Position) | View |
2020-03-06 4:30 pm Purchase | 13G | Passage BIO Inc. PASG | Vivo Capital VIII LLC | 2,243,497 4.9% | 2,243,497 (New Position) | View |